期刊文献+

艾滋病19例死亡原因分析 被引量:2

Analysis of death causes for 19 AIDS patients.
暂未订购
导出
摘要 目的分析艾滋病的死亡原因,以改进防治措施,降低病死率。方法对我院收治的19例获得性免疫缺陷综合征(AIDS)的死亡患者进行回顾性分析。结果19例AIDS死亡患者CD4+T细胞计数平均为(48.30±46.47)cells/mm3,可同时合并多种机会感染,63.16%的患者死于呼吸衰竭。结论呼吸衰竭是HIV死亡的常见原因。 Objective To analyze the death causes of patients with acquired immunodeficiency syndrome(AIDS) for improving treatment measures and decreasing the death rate of it.Methods To analyze retrospectively the death causes of 19 died inpatients with AIDS in our hospital.Results The average count of CD+4 T-cell was(48.30±46.47) cells/mm3.One and the same patient always had manifold HIV-related opportunistic infections.There were 63.16% patients died of respiratory failure.Conclusion Respiratory failure is the main death cause of AIDS patients.
出处 《四川医学》 CAS 2009年第9期1439-1441,共3页 Sichuan Medical Journal
关键词 艾滋病 艾滋病相关机会致病菌感染 死亡原因 acquired immunodeficiency syndrome HIV-related opportunistic infection death cause
  • 相关文献

参考文献8

  • 1王维真.我国艾滋病的流行形势与防治对策[J].中国护理管理,2005,5(6):9-11. 被引量:10
  • 2王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:633
  • 3Onyaneha OB, Oeholla DN. An imformetrie investigation of the related- ness of opportunistic infections to HIV/AIDS[ J]. Inform Proc Manag, 2005,41 (6) :1573 - 1588.
  • 4Bonnet F, Lewden C, May T, et al. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France [ J ]. Stand J Infect Dis,2005,37(6 -7) :482 -487.
  • 5刘彦春,李杏红,李兴旺,伦文辉,闫会文,葛蒙梁,朱学骏.690例HIV+/AIDS首诊病例的临床特征及与免疫状态和病毒载量相关性研究[J].中华流行病学杂志,2007,28(10):1026-1029. 被引量:9
  • 6张彤,吴昊,张可,徐连芝,孙桂珍.艾滋病患者死亡原因分析[J].首都医科大学学报,2002,23(2):148-150. 被引量:26
  • 7刘水腾,陆普选,周亚红,赖伟珍,刘艳,徐岩,童新灯,唐奇远,李健.20例艾滋病死亡原因分析[J].实用预防医学,2007,14(1):86-87. 被引量:11
  • 8Chariyalertsak S, Sirisanthana T, Saengwonloey O, et al. Clinical presentation and risk behaviors of patients with acquired immunodeficieney syndrome in Thailand, 1994-1998: regional variation and temporal trends[ J]. Clin Infect Dis,2001,32(6) :955 -962.

二级参考文献20

  • 1赵晓梅,吕维柏.311例艾滋病并发皮肤粘膜感染分析及中药治疗[J].中国医药学报,1996,11(2):55-56. 被引量:12
  • 2Kovacs J, Massur H. Prophylaxis against to opportunistic infections inpatients with human immunodeficiency virus infection. N Engl J Med,2000,342(19) :1416-1429.
  • 3Wannamethee SG, Sirivichayakul S, Phillips AN, et al. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand. Int J Epidemiol,1998,27(2):289-295.
  • 4Miller V, Mocroft A, Reiss P, et al. Relations among CD4 lymphocyte count nadir antiretroviral therapy, and HIV-1 disease progression: results from the euro AIDS study. Ann Intern Med, 1999,130(7) :570- 577.
  • 5Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-assoclated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis, 2000,30 Suppl 1 : S5-14.
  • 6Dore GJ,Hoy JF, Mallal SA, et al. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort. J Acquit Immune Defic Syndr Hum Retrovirol, 1997,16 (1) :39-43.
  • 7Maartens G,Wood R, O' Keefe E, et al. Independent epidemics of heterosexual and homosexual HIV infection in South Africa- survival differences. Q J Med, 1997,90(7) :449- 454.
  • 8Yazdanpanah Y,Chene G, Losina E, et al. Incidence of primary opportunistic infections in two human immunodeficiency virus infected French clinical cohorts. Int J Epidemiol, 2001,30 (4) : 864-871.
  • 9Jerene D,Endale A,Hailu Y, et al. Predictors of early death in a cohort of ethiopian patients treated with HAART. BMC Infect Dis,2006,6: 136.
  • 10Easterbrook PJ,Yu LM,Goetghebeur E. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. AIDS,2000,14(5) :561-571.

共引文献675

同被引文献21

  • 1郑毓芳,江雪艳,齐唐凯,刘莉,张仁芳,沈银忠,王江蓉,卢洪洲.89例hiv/aids患者死亡原因分析[J].中华临床感染病杂志,2008,1(1). 被引量:12
  • 2Ministry of Health of the People's Republic of China. 2012 China AIDS Response Progress Report [R/OL]. Beijing, Ministry of Health of the People's Republic of China, 2012. http://www, unaids, org/en/dataanalysis/knowyour- response/countryprogressreports/2012countries/ce CN Narra- tive_Report% 5B1% 5D. pelf.
  • 3中华人民共和国卫生部.2011年度全国法定传染病报告发病、死亡统计表[EB/0L].http://www.moh.gov.cn/pub-licfiles/business/htmlfiles/mohjbyfkzj/s3578/201202/54106.htm.
  • 4Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, Zhou S, Bulterys M, Zhu H, Chert RY. Effect of earlier in- itiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national ob- servational cohort study [J]. Lancet Infect Dis, 2011, 11 (7) :516-524.
  • 5Zhang Y, Dou Z, Sun K, Ma Y, Chen RY, Bulterys M, Zhao Y, Zhu H, Liu Z, Zhang F. Association between missed early visits and mortality among patients of China na- tional free antiretroviral treatment cohort [J]. J Acquir Im- mune Defic Syndr, 2012,60(1) : 59-67.
  • 6Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, Lundgren JD, Delpech V, Phillips AN. Projected life expectancy of people with HIV according to timing of diag- nosis [J]. AIDS, 2012,26(3):335-343.
  • 7Severe P, Juste M.A, Ambroise A, Eliacin L, Marchand C, Apollon S, Edwards A, Bang H, Nicotera J, Godfrey C, Gulick RM, Johnson WD Jr, Pape JW, Fitzgerald DW. Early versus standard antiretroviral therapy for H1V-infec- ted adults in Haiti [J]. N Engl J Med, 2010, 363(3): 257-265.
  • 8When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miro JM, Justice AC, Ledergerber B, Faitkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR. Timing of initiation of antiretroviral therapy in AIDS-free HIV-l-infected pa- tients.- a collaborative analysis of 18 HIV cohort studies [J]. Lancet, 2009,373(9672) :1352-1363.
  • 9World Health Organization. Rapid advice antiretroviral therapy for HIV infection in adults and adolescents. Gene- va, 2009 [EB/OL]. http://www, who. int/hiv/pub/arv/rapid_advice_art, pdf.
  • 10Department of Health and Human Services Panel on An- tiretroviral Guidelines for Adults and Adolescents. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-l-in- fected adults and adolescents VEB/OL3. In: Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. 2012. http://www, aidsinfo, nih. gov/content files/lvguidelines/adultandadolescentgl, pdf.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部